Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line

Author:      

Publisher: Spandidos Publications

ISSN: 1791-2997

Source: Molecular Medicine Reports, Vol.10, Iss.4, 2014-01, pp. : 2065-2072

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next